Predictive risk factors for Listeria monocytogenes meningitis compared to pneumococcal meningitis: a multicenter

Seungjin Lim1,2, Doo Ryeon Chung3, Yeon-Sook Kim4

  • 1Division of Infectious Diseases, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.

Infection
|August 20, 2016
PubMed
Abstract

Insights

Immunosuppressive therapy and chronic liver disease significantly increase the risk of Listeria monocytogenes meningitis compared to Streptococcus pneumoniae meningitis. These findings aid in identifying high-risk patients for early intervention.

Area of Science:

  • Infectious Diseases
  • Neurology
  • Epidemiology

Background:

  • Immunocompromised states elevate the risk of Listeria monocytogenes (LM) meningitis.
  • The comparative significance of various risk factors for LM meningitis remains unclear.

Purpose of the Study:

  • To identify and compare risk factors for LM meningitis versus Streptococcus pneumoniae (SP) meningitis.
  • To establish the relative importance of immunocompromising conditions in predicting LM meningitis.

Main Methods:

  • A nationwide, multicenter case-control study was conducted in Korea from 1998 to 2013.
  • LM meningitis cases were compared with SP meningitis controls.
  • Multivariate logistic regression analysis identified predictive risk factors.

Main Results:

  • Thirty-six LM meningitis cases and 113 SP meningitis controls were analyzed.
  • Prior immunosuppressive therapy was the strongest predictor (OR 8.12).
  • Chronic liver disease was the second most significant factor (OR 5.03).

Conclusions:

  • Patients on immunosuppressive therapy within one month face an 8.1-fold higher risk of LM meningitis.
  • Chronic liver disease confers a 5-fold increased risk for LM meningitis compared to SP meningitis.